GSK Settles 10,000 Avandia Cases For $460M
GlaxoSmithKline PLC has agreed to shell out $460 million to settle approximately 10,000 product liability suits over the drugmaker's diabetes drug Avandia, as federal regulators convene to determine the fate of...To view the full article, register now.
Already a subscriber? Click here to view full article